Font, A <br/><br/>
Increasing dose intensity of cisplatin-etoposide in advanced nonsmall cell lung carcinoma: a phase III randomized trial of the Spanish Lung Cancer Group.  [electronic resource] 

 -  Cancer  Feb 1999 
 - 855-63 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/(sici)1097-0142(19990215)85:4<855::aid-cncr12>3.0.co;2-r  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Agranulocytosis--chemically induced<br/>Analysis of Variance<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Etoposide--administration & dosage<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Neutropenia--chemically induced<br/>Survival Analysis<br/>Thrombocytopenia--chemically induced<br/>Treatment Outcome